Both the Giant companies of India will be creating an Oil company together over the Globe. However Devin McCourty Hoodie , the merged entities will be smaller in size than the peers. Yesterday, the Union Cabinet approved the request of ONGC to buy the government鈥檚 51.1% stake in Hindustan Petroleum Corporation. Both of the oil Giant companies are owned and operated by public sectors. ONGC is an upstream company, where the process of extraction of oil is carried out. All the impurities from the oil are extracted from the oil.
In HPCL, the refining of oil is carried out once the extraction is been done. It makes sub-products of oil. The deal of both the companies reflects the plan of government to create an integrated oil giant. This was also proposed in Union budget of this year. The deal is been looked out from both the aspects of pros and cons by the industry experts. The benefits of deals
The deal might be a big step achieving the divestment target of the government that was set at Rs 72 Stephen Gostkowski Hoodie ,500 crore for this financial year in the Union Budget. Now HPCL will be the subordinate of ONGC and will give the resources to keep a check on the operations of former. The deal of both the state-owned entities will be responsible for improving efficiency. Both the entities might find effective ways of cutting costs and growing the output. The side-effects of a deal: Industry experts believe that BPCL could have been a better option rather than choosing HPCL for the merger. There could have been the better probability of ONGC merging with BPCL than with HPCL of the government's aim to boost the exploration and production strength of India.
Due to a difference in nature of operations in both the oil giants, there can be clashes, which may lead to interference from the parent. ONGC does not have a high capital allocation record thus the long-term holders is a concern. At times, when crude prices are low Dont'a Hightower Hoodie , HPCL may not avail good benefits from the deal.
Total Views: 130Word Count: 335See All articles From Author
The market for anti-cancer drugs will usher in a high growth Marketing Articles | March 2, 2012 The annual growth rate of global cancer drug market will reach 15%. It is significantly more than the growth rate of other drugs (including cardiovascular disease drugs).
By 2012, total sales of the global cancer drug market will reach $ 80 billion. Newly industrialized countries such as China, India James White Hoodie , Brazil and Russia will become the high incidence countries of lung cancer. Smokers in these countries are about 60% of total number of smokers, while smoking is recognized as a reason of induced lung cancer by the docetaxel medical professions.
The number of patients is increasing as levels of medical diagnosis and high-end diagnostic imaging equipment improves rapidly. The number of breast cancer, lung cancer, gastric cancer and other common tumor diseases increase. According to WHO statistics Tom Brady Hoodie , in 2007, the world's newly diagnosed cancer patients as many as 12 million over the past few years, the world die each year from cancer patients up to 700 million. This figure is very close to the number of people died of acute cardiovascular disease. In addition to the incidence of cancer in the developing and newly industrialized countries increased incidence of cancer in the US-led Western developed countries is equally high.
Statin lipid-lowering drugs throughout the 1990s has been ranked first in the international pharmaceutical raw materials market. In 2005, the total sales are $ 29.5 billion. But it has long been anti-cancer drugs in general beyond the specific varieties. Although sales of statins is still rising Rob Gronkowski Hoodie , but they are compared with the sales of anti-cancer drugs in recent years is not worth mentioning. Statins to step aside the fact that the anti-cancer drugs will soon become a major drug major categories of varieties dominate the world pharmaceutical market.
U.S. men the highest incidence of neoplastic diseases of prostate cancer a few years ago, and the current lack of effective drugs for the treatment of prostate cancer, so the prostate cancer vaccine in the United States is developing several. To date, bio-engineering vaccine being developed in cancer prevention at least as much as 20 to 30 kinds. Once they put on the market Jake Bailey Hoodie , will greatly enhance the sales of the global cancer drug market.